What Is the Evidence for Endovascular Thrombectomy in Posterior Circulation Stroke?
Journal
Seminars in neurology
ISSN: 1098-9021
Titre abrégé: Semin Neurol
Pays: United States
ID NLM: 8111343
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
medline:
21
8
2023
pubmed:
19
8
2023
entrez:
18
8
2023
Statut:
ppublish
Résumé
Posterior circulation infarcts comprise approximately 25% of ischemic strokes but are less often treated with recanalization therapy and have longer treatment delays compared with anterior circulation strokes. Among posterior circulation strokes, basilar artery occlusion is associated with the most severe deficits and the worst prognosis. Endovascular thrombectomy is a standard of care for patients with anterior circulation large vessel occlusion, but not until recently were the first randomized controlled trials on endovascular thrombectomy in basilar artery occlusion published. Two of the trials were neutral, whereas two others showed better functional outcome after thrombectomy up to 24 hours of symptom onset compared with best medical treatment, which in most cases had low rates of intravenous thrombolysis. According to observational data, thrombectomy seems to be safe also in isolated posterior cerebral artery occlusions and might be an option for selected patients, even if its outcome benefit is yet to be demonstrated.
Identifiants
pubmed: 37595603
doi: 10.1055/s-0043-1771210
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
345-355Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
S.R.: Junior member of working group for ESO-ESMINT Guideline on acute management of basilar artery occlusion.T.N.N.: Research support from Medtronic, Society of Vascular and Interventional Neurology, not related.S.N.: Personal fees from Brainomix (consulting), Bristol Myers Squibb, and Böhringer Ingelheim (lectures), all not related.V.P.: Member of the executive committee of the BASICS trial, personal fees from Bristol Myers Squibb and Daiichi Sankyo (lectures), not related.F.A.: Research support from the Medical Research Future Fund, the Australian Heart Foundation, and the Sylvia & Charles Charitable Foundation.M.A.: None.W.J.S.: Principal investigator of the BASICS trial.D.S.: Chair of working group for ESO-ESMINT Guideline on acute management of basilar artery occlusion.